CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced it granted equity awards on July 1 and July 15, 2025, to 30 new non-executive employees as part of its 2025 Inducement Plan. The awards were approved by Madrigal’s independent Compensation Committee in line with Nasdaq Listing Rule 5635(c)(4).
The equity awards were offered as an incentive for employees to join the company. The new hires received options to purchase 5,675 shares of Madrigal’s common stock and 19,863 time-based restricted stock units. Options granted on July 1, 2025, have an exercise price of $300.16, while those on July 15, 2025, have a price of $311.14, matching the stock’s closing price on the respective grant date. Options vest as follows: 25% after one year, with 6.25% vesting quarterly afterward. Restricted stock units vest in four equal installments on each anniversary of the grant date. All awards require continued employment through each vesting date.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.